Research peptides in vials
A 21-product portfolio organized by research area, with information and availability for validated institutions.
21View profile21 vial compounds and five sublingual ODF formulations for clinics, hospitals and research centers, supported by technical information, institutional service and local distribution across Latin America.

Explore 21 research products presented in vials and five ODF formulations in development for institutional evaluation.
A 21-product portfolio organized by research area, with information and availability for validated institutions.
21View profileFive oral dissolving film formulations in development, each with its own product identity and no visible corporate branding on pack.
05View ODF lineAn institutional structure combining two product platforms with technical information and local coordination.
Twenty-one vial products and five ODF formulations organized for clear institutional evaluation.
Technical information and documentation available by product, batch and institutional requirement.
Operational coordination for institutions in Mexico, Colombia, Brazil, Central America and the Caribbean.
Explore research areas relevant to specialized clinics. Each institution independently assesses product relevance within its protocols.
Research into metabolic mechanisms and compounds active at related receptors.
Research lines for institutions studying biological ageing and cellular processes.
An institutional view connecting metabolism, cellular energy, neuroscience and the hormonal axis.
Products organized for research in aesthetic dermatology, skin and hair.
Scientific assessment of mechanisms associated with tissue response.
Products for institutions researching mechanisms related to the hormonal axis.
Compounds grouped for research into processes associated with cellular energy.
An area for centers researching mechanisms related to neuroscience and cognition.
Institutional access to products organized within sexual-health research.
Research products grouped for institutions specializing in the immune system.
Research areas, not therapeutic indications. Veyra does not diagnose, prescribe or define clinical protocols.
A 21-product portfolio organized by research area, with information and availability for validated institutions.

Agonista de los receptores GLP-1, GIP y glucagón.

Molécula con actividad combinada sobre los receptores GIP y GLP-1.

Análogo sintético de la hormona liberadora de hormona de crecimiento.

Péptido de 16 aminoácidos codificado por el ADN mitocondrial.

Pentadecapéptido sintético relacionado con una secuencia de proteína gástrica.

Perfil combinado de BPC-157 y un fragmento relacionado con timosina beta-4.
Products exclusively for research. Availability, presentation and documentation are confirmed directly with each institution.
Oral dissolving films offer a modern, hassle-free format for active ingredients. These compact strips dissolve quickly on the tongue, without the need for water or bulky packaging.

Veyra Oral Dissolving Films use high-quality, naturally derived ingredients and contain no fillers, sugar, gluten, soy or common allergens.
The ODF format offers a compact alternative to tablets and capsules for protocols investigating water-free oral administration. Each strip can be individually packaged, supporting handling and operational standardisation.
A delivery platform for institutions evaluating:
Practical properties of the platform:
Five oral dissolving film formulations in development, each with its own visual identity and no visible corporate branding on pack.
Each validated institution receives ongoing support to understand the portfolio, request documentation and coordinate requirements with confidence.
Guidance on presentation, preparation, storage, documentation and responsible product handling.
A dedicated channel for product, documentation and operational coordination requirements.
Clear resources that help authorized professionals understand each line without relying on promotional messaging.
Timely information about documentation, availability, new presentations and relevant portfolio changes.
Share corporate details so we can confirm the institutional profile.
Choose a line or product and request the information your team needs.
Access direct contact, available documentation and operational follow-up.
Veyra does not diagnose, prescribe, design protocols or assess patients. Support does not replace the institution's medical, nutritional, scientific, ethical or regulatory judgment.

We work exclusively with clinics, hospitals and research centers, combining product supply, document control and operational support through local distribution in Mexico, Colombia, Brazil, Central America and the Caribbean.
Validate your institution and request technical information or operational support.